| NCT ID | NCT03072537 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Leipzig |
| Condition | Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000,000 participants |
| Start Date | 1998-01-01 |
| Primary Completion | 2028-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000,000 participants in total. It began in 1998-01-01 with a primary completion date of 2028-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
CrescNet is a network of primary care physicians and pediatricians (n=219) and endocrinological treatment centers (n=33), established in Leipzig in 1998, whose aim is to improve the early detection of growth disorders. Secondary to this clinical aim, epidemiological analyses, for example on secular trends of growth data of children, are performed.
Eligibility Criteria
Inclusion Criteria: Population based sample with inclusion of any patient seen by primary care or institutional physician/pediatrician, regardless of the objective for the visit (well child visits, acute visits or special requests) Exclusion Criteria: none
Contact & Investigator
Roland W Pfäffle, MD
✉ roland.pfaeffle@medizin.uni-leipzig.deRoland W Pfäffle, MD
PRINCIPAL INVESTIGATOR
University of Leipzig
Frequently Asked Questions
Who can join the NCT03072537 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03072537 currently recruiting?
Yes, NCT03072537 is actively recruiting participants. Contact the research team at roland.pfaeffle@medizin.uni-leipzig.de for enrollment information.
Where is the NCT03072537 trial being conducted?
This trial is being conducted at Leipzig, Germany.
Who is sponsoring the NCT03072537 clinical trial?
NCT03072537 is sponsored by University of Leipzig. The principal investigator is Roland W Pfäffle, MD at University of Leipzig. The trial plans to enroll 1,000,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.